A detailed history of Fort Sheridan Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fort Sheridan Advisors LLC holds 98,434 shares of MRK stock, worth $9.65 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
98,434
Previous 98,712 0.28%
Holding current value
$9.65 Million
Previous $12.2 Million 8.53%
% of portfolio
1.72%
Previous 1.99%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $30,899 - $35,853
-278 Reduced 0.28%
98,434 $11.2 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $966,259 - $1.04 Million
7,805 Added 8.59%
98,712 $12.2 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $345,155 - $402,183
3,048 Added 3.47%
90,907 $12 Million
Q3 2023

Nov 08, 2023

BUY
$102.95 - $114.33 $341,382 - $379,118
3,316 Added 3.92%
87,859 $9.05 Million
Q2 2023

Aug 01, 2023

BUY
$108.61 - $118.38 $453,663 - $494,473
4,177 Added 5.2%
84,543 $9.76 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $2.03 Million - $2.26 Million
19,697 Added 32.47%
80,366 $8.55 Million
Q4 2022

Feb 15, 2023

SELL
$87.44 - $112.11 $253,313 - $324,782
-2,897 Reduced 4.56%
60,669 $6.73 Million
Q3 2022

Nov 09, 2022

BUY
$84.53 - $94.96 $34,572 - $38,838
409 Added 0.65%
63,566 $5.47 Million
Q2 2022

Aug 08, 2022

BUY
$83.49 - $94.64 $647,130 - $733,554
7,751 Added 13.99%
63,157 $5.76 Million
Q1 2022

May 09, 2022

BUY
$73.51 - $82.4 $197,888 - $221,820
2,692 Added 5.11%
55,406 $4.55 Million
Q4 2021

Feb 10, 2022

SELL
$72.28 - $90.54 $77,773 - $97,421
-1,076 Reduced 2.0%
52,714 $4.04 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $100,710 - $110,756
1,405 Added 2.68%
53,790 $4.04 Million
Q2 2021

Aug 17, 2021

BUY
$70.31 - $77.77 $592,010 - $654,823
8,420 Added 19.15%
52,385 $4.07 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $417,085 - $491,283
6,057 Added 15.98%
43,965 $3.39 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $31,578 - $35,046
440 Added 1.17%
37,908 $3.1 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $2,927 - $3,318
40 Added 0.11%
37,468 $3.11 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $84,644 - $96,316
1,202 Added 3.32%
37,428 $2.89 Million
Q1 2020

May 12, 2020

BUY
$63.36 - $87.82 $184,060 - $255,117
2,905 Added 8.72%
36,226 $2.79 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $69,666 - $78,610
898 Added 2.77%
33,321 $3.03 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $23,584 - $25,708
310 Added 0.97%
32,423 $2.73 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $160,632 - $187,657
2,300 Added 7.71%
32,113 $2.69 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $208,740 - $238,080
3,000 Added 11.19%
29,813 $2.48 Million
Q4 2018

May 13, 2019

BUY
$65.24 - $75.71 $1.75 Million - $2.03 Million
26,813 New
26,813 $2.05 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fort Sheridan Advisors LLC Portfolio

Follow Fort Sheridan Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.